As pediatricians who take care of children in the inpatient, emergency, and primary care settings, we are alarmed by the recent trend of families having to go without basic medications to control their child’s asthma. At least seven children have died due to uncontrolled asthma this year in the Philadelphia region, a dramatic increase from prior years. At our institution, admissions for intensive care to support children with asthma have nearly doubled from the pre-pandemic baseline, and admissions for asthma are up 50% in March and April compared to last year.
This increase in child asthma acuity and deaths is likely multifactorial, but access to basic medications is one modifiable driver. Limited access stems from three main issues: the discontinuation of a common branded asthma medication, lack of insurance coverage for its generic alternative, and shortages of a similar branded alternative.
Click this link for the original source of this article.
Author: Chén Kenyon, Bianca Nfonoyim Bernhard, and Tyra Bryant-Stephens
This content is courtesy of, and owned and copyrighted by, https://www.statnews.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.